CD38

359 ‒ How metabolic and immune system dysfunction drive the aging process, NAD, aging clocks, & more

Peter Attia MD

A major driver of NAD+ decrease during aging, shown by Eduardo Chini's work. CD38 knockouts have stable NAD+ levels and live 15% longer.